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August 2012582 AbstractsConclusions: Overall, EH for infrainguinal arterial bypass confers no
additional benefit in wound complication or bypass patency rates compared
with OH. However, the possibility that bypass patency may be enhanced by
EH in the nonhemodialysis population deserves further study.
Outpatient Common Femoral Artery Stenting: Midterm Outcomes
Sam S. Ahn, MD, Monica J. Uceda, MD, Kenneth R. Kollmeyer, MD,
Craig A. Ferrara, DO, and Pablo V. Uceda, MD. DFW Vascular Group,
Dallas, Texas
Objective: Stenting of common femoral artery (CFA) lesions is con-
troversial. The purpose of this study was to demonstrate the safety, efficacy,
and midterm outcomes of CFA stenting.
Methods: From January 2009 to December 2011, 61 patients, 29 men
(48%) and 32 women, underwent CFA stenting in our outpatient office angio-
suite. Patients were a mean age of 67.28  9.85 years. The most common
comorbidities were hypertension (91.8%), smoking (59%), hyperlipidemia
(59%), and diabetes (39.34%). Indications for the procedure were moderate
claudication (4.35%), severe claudication (50.72%), ischemic rest pain
(37.68%), and nonhealing ulcer (7.25%). We retrospectively analyzed the out-
comes of 69 CFA lesions by evaluating clinical improvement and patency.
Results: Follow-up for clinical improvement showed 30 patients
(44.12%) achieved the “markedly improved” Rutherford classification,
14 (20.59%) were “moderately improved,” and the condition worsened
in seven (10.29%). The cumulative primary patency rate was 94% at 3
months, 82% at 6 months, 71% at 9 months, and 67% at 12 months,
remaining the same over 24 months. Cumulative primary assisted pa-
tency was 100% at 21 months. Thirteen cases (19%) were considered as
failures. Concomitant vascular stenting in other vessels was performed in
58 patients (83.82%). The only postoperative complication was a groin
hematoma in one patient (1.47%). Twenty stents (29.41%) subsequently
were punctured, without complications, to achieve access for other
endovascular procedures.
Conclusions: Stenting of CFA lesions with self-expandable stents is
safe and effective in the outpatient office setting. Puncturing the CFA stent
for subsequent endovascular access is also safe and effective.
Clinical Consequence of Bare-Metal Stent and Stent Graft Failure in
Femoropopliteal Occlusive Disease
Shant M. Vartanian,1 Paul J. Johnston,2 Joy P. Walker,1 Sara J. Runge,1
Charles M. Eichler,1 and Michael S. Conte1. 1University of California–San
Francisco, San Francisco, Calif; and 2Colorado Permanente Medical Group,
Denver, Colo
Objective: The optimal role for bare-metal stents (BMS) and stent
grafts (SG) in treating femoropopliteal occlusive disease (FPOD) is as yet
undefined. Understanding the clinical consequences of failure can help
guide initial treatment decisions. The goal of this study was to define the
nature and frequency of adverse clinical events related to BMS and SG failure
in FPOD.
Methods: This is a single-institution retrospective review of the pri-
Fig.mary endovascular intervention for FPOD, treated with BMS or SG, from
September 2007 through October 2011. Patient demographics, indications
(
ror intervention, anatomic characteristics, procedural details, clinical outcomes,
nd reintervention details were reviewed. Patients were excluded if they had any
revious lower extremity interventions or inadequate follow-up.
Results: Of the 127 limbs from 97 patients that met the inclusion
riteria, 67 were treated with BMS and 60 with SG. Follow-up averaged 551
ays for BMS and 690 days SG. The indication for intervention was similar
etween groups (49% vs 68% claudication; P  .15). Baseline patient
haracteristics were similar between groups, with the exception of more
ransAtlantic Inter-Society Consensus (TASC) D lesions (9 of 67 vs 26 of
0, P  .01) and chronic total occlusion (18 of 67 vs 35 of 60; P  .01) in
he SG group. Freedom from reintervention of the index procedure was
ore likely with SG (28 of 67 vs 40 of 60, P  .01). For both groups, the
ndications for reintervention of the index procedure were prompted by
hanges in symptoms or physical examination findings rather than by abnor-
al findings on surveillance ultrasound imaging (9 of 39 vs 3 of 20). Only
atients in the SG group presented with acute limb ischemia (0 vs 6, P 
01); however, the major adverse limb event rate was not different between
roups (11 vs 10, P .9). The 127 limbs needed 96 primary and secondary
nterventions during the course of the study. Including both primary and
econdary interventions, only patients treated with SG presented with acute
imb ischemia (0 vs 11, P  .1).
Conclusions: Reinterventions are common in both groups; however,
G failure is more likely to present with acute limb ischemia than BMS
ailure. These observations should be carefully considered when treating
POD with BMS or SG.
urgical Treatment of Lower Extremity Venous Aneurysms
rant T. Fankhauser, MD,1 William M. Stone, MD,1 Richard J. Fowl, MD,1
anju Kalra, MBBS,2 Peter Gloviczki, MD,2 W. Andrew Oldenburg, MD,3
nd Samuel R. Money, MD1. 1Division of Vascular Surgery, Mayo Clinic
rizona, Phoenix, Ariz; 2Mayo Clinic, Rochester, Minn; and 3Mayo Clinic
lorida, Jacksonville, Fla
Objective: Lower extremity venous aneurysms are rare. Their symp-
oms, diagnosis, and treatment are varied. The purpose of this study was to
eview our contemporary experience in managing these unusual entities and
efine the treatment options.
Methods: A retrospective review from 1994 to 2011 was conducted at
hree geographically separate institutions. Basic demographics, diagnostic
orkup, treatment, and follow-up were reviewed.
Results: The review included 14 patients with lower extremity venous
neurysms. There were four male patients (29%) and 10 female patients
71%), with a mean age of 46 years (range 14-74 years). The 14 aneurysms
onsisted of seven popliteal vein (50%), three great saphenous vein (21%),
wo small saphenous vein (14%), one common femoral vein (FV) (7%), and
ne FV (7%). Symptoms that led to the diagnosis were pain (n  6, 43%),
eep vein thrombosis (DVT; n  4, 29%), palpable mass (n  2, 14%),
neurysm rupture (n  1, 7%), and knee injury (n  1, 7%). Inferior vena
ava filters were placed preoperatively in two patients with pulmonary
mbolism from popliteal DVT. The five patients with great/small saphenous
ein aneurysms underwent excision. The 10 patients with popliteal, FV, or
ommon FV aneurysms underwent aneurysmectomy with venorrhaphy (n
), aneurysmectomy with interposition saphenous vein graft (n  4), or
neurysm excision with end-to-side anastomosis to the great saphenous vein
Fig.FV, n  1). Surgical complications included three (21%) hematomas
equiring surgical evacuation, two (14%) postoperative thromboses requir-
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Volume 56, Number 2 Abstracts 583ing anticoagulation, and two patients (14%) with postoperative edema.
Eight of nine patients (89%) with venous reconstruction underwent imaging
at a mean of 292 days postoperatively. All reconstructions were patent.
There have been no recurrences to date after a mean follow-up of 483 days
(range, 6-3800 days). All patients with PE were anticoagulated for 6
months, and those with DVT were anticoagulated for 3 to 6 months.
Conclusions: Lower extremity venous aneurysms are infrequently
encountered and most often present with symptoms of pain or DVT.
Rupture is rare but possible. Popliteal and saphenous vein aneurysms can
present with DVT. Surgical options vary depending on aneurysm location
and need for maintenance of vessel patency.
Factors Impacting Follow-Up Care After Placement of Temporary
Inferior Vena Cava Filters
Elsie Gyang, MD, MSc, Mohamed Zayed, MD, PhD, E. John Harris, MD,
Jason Lee, MD, Ronald Dalman, MD, and
Matthew Mell, MD, MS. Vascular Surgery, Stanford University, Stanford,
Calif
Objective: Rates of inferior vena cava filter (IVCF) retrieval have
remained suboptimal, partly because of poor follow-up. The goal of our
study was to determine demographic and clinical factors predictive of IVCF
follow-up care in a university hospital setting.
Methods: We reviewed 250 consecutive IVCFs placed with the inten-
tion of subsequent retrieval between March 2009 and October 2010.
Patient demographics, clinical factors, and physician specialty were evalu-
ated. Multivariate logistic regression analysis was performed to identify
variables predicting follow-up care.
Results: Of our cohort, 54% received follow-up care, and the IVCF
was retrieved in 95%. Major indications for IVCF placement included
prophylaxis for high-risk surgery (49%) and venous thromboembolic
event with contraindication or failure of anticoagulation (42%), or both.
Follow-up care was less likely for patients discharged to acute rehabilita-
tion or skilled nursing facilities (P  .001), those with central nervous
system pathology (eg, cerebral hemorrhage or spinal fracture; P  .001),
and those whose IVCF was not placed by a vascular surgeon (P  .001).
In a multivariant analysis, discharge home (odds ratio [OR], 4.0; 95%
confidence interval [CI], 1.99-8.2; P  .001), central nervous system
pathology (OR, 0.46; 95% CI, 0.22-0.95; P  .036), and IVCF place-
ment by the vascular surgery service (OR, 4.7; 95% CI, 2.3-4.9; P 
.001) remained independent predictors of follow-up care. Trauma status
and distance of residence did not significantly affect patient follow-up.
Conclusions: Service-dependent practice paradigms play a critical
role in patient follow-up and IVCF retrieval rates. Nevertheless, specific
patient populations are more prone to having poorer rates of follow-up.
Such trends should be factored into institutional quality control goals
and patient-directed care.
The Efficacy of a Shortened Duration of Propranolol Therapy in the
Treatment of Infantile Hemangioma
Jason Q. Alexander, MD, Stephen Nelson, MD, and
Anna C. Griffin. Vascular Specialists of Minnesota, Minneapolis Heart
Institute, Minneapolis Children’s Hospital and Minneapolis Heart Institute
Foundation at Abbott Northwestern Hospital, Minneapolis, Minn
Objective: Propranolol has been shown to be an effective treatment for
symptomatic hemangioma of infancy. Current treatment regimens extend
the duration of therapy from initial dosing until the patient reaches the age
of 12 months. Unfortunately, the side effects from treatment are common
and often extend throughout the duration of treatment. Our goal is to
determine if shortening the duration of treatment will be effective in
managing infantile hemangioma.
Methods: All patients aged 13 months who presented to a multi-
disciplinary vascular anomalies center with a diagnosis of infantile hem-
angioma during an 18-month period were prospectively treated with a
shortened duration of therapy using oral propranolol. Patients were
treated for 16 to 20 weeks. If the hemangioma remained evident at the
16- or 20-week check, therapy was continued until the hemangioma was
no longer evident.
Results: Forty-nine patients (33 girls and 16 boys) were treated. The
average age at onset of treatment was 14 weeks (range, 3-56 weeks). Average
duration of treatment was 23 weeks (range, 8-56 weeks). Treatment in 23
patients extended 20 weeks because of failure of hemangioma resolution.
Nine of the 49 patients (18%) developed recurrences. Four of the recurrences
occurred in 26 patients (15%) treated for 20 weeks. All of these patients
responded to a second course of treatment extended to the patient reaching age
12 months. Three patients (6%) ultimately did not respond to propranolol
treatment.
Conclusions: This study once again demonstrates the effectiveness
of propranolol in the treatment of infantile hemangioma. In addition, a
shortened duration of treatment, 20 weeks of therapy, is effective in
patients whose hemangiomas clinically resolve during that period. The
recurrence rate for these patients is low. Those patients that do recur
c
flespond well to a second course of treatment. Shortening the course of
reatment in these patients minimizes the effect of the side effects from
ropranolol.
eometric Changes of the Inferior Vena Cava in Trauma Patients
ndergoing Volume Resuscitation: Insight into Dynamic Stresses
laced on Inferior Vena Cava Filters
amuel L. Chen, Thangavijayan Bosemani, MD, Mayil S. Krishnam, MD,
ohn S. Lane III, MD, and Roy M. Fujitani, MD. Department of Surgery,
ivision of Vascular and Endovascular Surgery and Division of Cardiovas-
ular and Thoracic Imaging, University of California–Irvine School of
edicine, Orange, Calif
Objective: Dynamic changes in the anatomic geometry of the inferior
ena cava (IVC) from changes in intravascular volume status may cause
assive stresses on IVC filters. This study quantified the variability in IVC
imensions and anatomic orientation as influenced by intravascular volume
hanges to determine how it may affect complications of IVC filter place-
ent including migration, tilting, and perforation.
Methods: Retrospective computed tomography (CT) measurements
f major and minor axis along with horizontal diameter of the IVC at 1 and
cm below the lowest renal veins (RVs) were assessed in 58 adult trauma
atients in hypovolemic and postresuscitative states. IVC perimeter area
nd volumetric measurements were calculated and correlated with caval
rientation.
Results: The mean volumes of the IVC segment were 9.34 mL on
he initial CT scan and 11.52 mL on follow-up CT scans, with a mean
ncrease of 51.5% (P  .01). At 1 and 5 cm below the RVs, the IVC
xpanded anisotropically, with the minor axis expanding by an average of
3.3% (P  .001) and 31.3% (P  .01), respectively, whereas the major
xis only changed by 4.9% (P  .15) and 6.8% (P  .025). Surface area
nd perimeter at 1 cm below the lowest RV expanded by 67.5% (P 
001) and 11.2% (P  .01). At 5 cm below, the expansion of surface area
nd perimeter was 44.2% (P  .01) and 11.4% (P  .001). The IVC
rientation was left anterior-oblique in all patients. Horizontal measure-
ent significantly underestimated the IVC maximal diameter. With
ypovolemia, at 1 and 5 cm below the lowest RV, the discrepancies
etween the horizontal and major axis diameters were 2.60  1.27 mm
P  .001) and 2.13  1.35 mm (P  .001), respectively, whereas the
ostresuscitation CT showed the same underestimation at 1 and 5 cm
elow the lowest RV, at 2.56 1.25 mm (P .01) and 2.38 1.15 mm
P  .01), respectively.
Conclusions: There is significant anisotropic variability of the infrare-
al IVC geometry, with significantly greater expansive and compressive
orces in the minor axis. There can be significant volumetric changes in the
VC with associated perimeter changes, but the left anterior-oblique caval
onfiguration is always maintained. These significant dynamic forces are
ikely to affect IVC filter stability after implantation. The consistent obliquity
ay lead to underestimation of the IVC diameter used in anteroposterior
enography and may influence initial filter selection.
ongenital, Meandering Transdiaphragmatic Aortocaval-Right Atrial
rteriovenous Fistula
oy M. Fujitani, MD, Samuel L. Chen, MD, John S. Lane III, MD, and
ayil S. Krishnam, MD. Division of Vascular/Endovascular Surgery and
ivision of Cardiovascular and Thoracic Imaging, University of California,
rvine School of Medicine, Orange, Calif
Objective: We present a unique case of a high-flow, congenital,
ortocaval-right atrial arteriovenous vascular anomaly that remained
ndetected until late adulthood. The patient is 66-year-old white woman
ith chronic, intractable rate-controlled atrial fibrillation who presented
ith a chief complaint of new-onset, nonfocal abdominal pain and
atigue.
Methods: A computed tomography angiogram demonstrated a
arge, tortuous, arterial conduit that originated in the paravisceral ab-
ominal aorta just above the right native renal artery, traversed through
he right hemidiaphragm, and emptied into the suprahepatic inferior
ena cava near its insertion into the right atrium. The vessel was further
valuated with gadolinium-enhanced three-dimensional magnetic reso-
ance angiography, which measured the anomalous vessel to be 11 mm at
ts aortic origin; averaging 10 mm throughout its course, with focal
neurysmal dilatation to 17 mm at the focus of emptying into the inferior
ena cava. Time-resolved magnetic resonance angiography demonstrated
.2 L/min flow through the fistula, with a Qp/Qs ratio of 1.2. Chest
adiography and echocardiography demonstrated marked cardiomegaly.
wing to the high-flow nature of the vessel and associated symptoms,
ercutaneous transaortic and transcaval arteriovenous fistulography was
erformed. Test balloon occlusion of the conduit did not result in any
dverse hemodynamic changes. The conduit was occluded with endovas-
ular Amplatzer Vascular Plugs, resulting in complete cessation of blood
ow.
